发明名称 Enhancement of skeletal muscle stem cell engraftment by dual delivery of VEGF and IGF-1
摘要 An improved device and method for extended repair and regeneration of muscle tissue. An exemplary device comprises (a) a scaffold comprising an ECM component; (b) a combination of growth factors such as VEGF and IGF; and (c) a population of myogenic cells. Implantation of the device leads to muscle regeneration and repair over an extended period of time.
申请公布号 US9610328(B2) 申请公布日期 2017.04.04
申请号 US201113582900 申请日期 2011.03.07
申请人 President and Fellows of Harvard College 发明人 Mooney David J.;Borselli Cristina;Vandenburgh Herman;Shvartsman Dimitry;Storrie Hannah;Lichtman Jeff
分类号 A01N63/00;C12N5/00;A61K38/18;A61K38/30;A61L27/36;A61L27/38;A61L27/52;A61L27/54;A61L27/56;A61K35/34;A61K35/12 主分类号 A01N63/00
代理机构 McCarter & English, LLP 代理人 McCarter & English, LLP ;Zacharakis Maria Lacocotripe
主权项 1. A method of enhancing muscle tissue repair or regeneration, comprising introducing into a muscle tissue of a human subject an injectable device comprising an alginate hydrogel comprising a combination of vascular endothelial growth factor 165 (VEGF165) and insulin-like growth factor-1 (IGF-1), wherein the alginate hydrogel comprises oxidized alginate, wherein the VEGF165 and the IGF-1 are released from the device into said muscle tissue, and wherein introduction of said device comprising a combination of VEGF165 and IGF-1 provides a synergistic muscle tissue regeneration effect in the human subject.
地址 Cambridge MA US